Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Clin Trials. 2021 May 27;18(4):391–397. doi: 10.1177/17407745211018613

Table 1.

Summary of Notation in Equations for Statistical Methods

CI Confidence Interval
L Number of primary events in a Cox regression analysis
V Variance of the estimated log Hazard Ratio in a Cox regression analysis
HR Hazard ratio
VE Vaccine efficacy
Δ, δ, δ0 Non-inferiority margins used in Stratum ‘A’
TP, TA Test statistics using data from Stratum ‘P’ and Stratum ‘A’, respectively
LP Observed number of events in Stratum ‘P’
L0P Number of events needed in Stratum ‘P’ alone to achieve 90% statistical power
LA Observed number of events in Stratum ‘A’
L0A Number of events needed in Stratum ‘A’ alone to achieve 90% statistical power
HR0, HR1 Experimental vaccine to placebo hazard ratios, under the null and alternative hypotheses, in Stratum ‘P’
VE0 Vaccine efficacy of the experimental vaccine, under the null hypothesis, in Stratum ‘P’
HRP Estimated experimental vaccine to placebo hazard ratio using data in Stratum ‘P’
HRA Estimated experimental vaccine to active comparator vaccine hazard ratio using data in Stratum ‘A’
VE*, HR* Estimated vaccine efficacy and hazard ratio from the placebo-controlled evaluation of the Active Comparator Vaccine
tR Calendar date when it is no longer proper to continue randomization to placebo
tF Calendar date when it is no longer proper for participants randomized to placebo to remain on placebo and in follow-up